REVIEW Ulipristal acetate is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma. Ulipristal acetate is used as an emergency contraceptive in women. A single dose of 30 mg ulipristal acetate has recently been proposed for the emergency contraception use up to 120 h of unprotected intercourse with similar side effect profiles as levonorgestrel.
Jadav SP, Parmar DM. Ulipristal acetate, a progesterone receptor modulator for emergency contraception. J Pharmacol Pharmacother. 2012 Apr;3(2):109-11.
Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther. 2012 Aug;29(8):655-63.
Nallasamy S, Kim J, Sitruk-Ware R, et al. Ulipristal Blocks Ovulation by Inhibiting Progesterone Receptor-Dependent Pathways Intrinsic to the Ovary. Reprod Sci. 2012 Sep 25.
For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.